Abstract:Medium-chain fatty acids (MCFAs), a class of saturated fatty acids that exist naturally in dairy products and tropical oils, can regulate inflammation, insulin resistance, and immune response. Furthermore, in vitro and in vivo studies found MCFAs have strong anticarcinogenic properties. Recent evidence reveals MCFAs inhibits aerobic glycolysis in tumor cells. It is conceivable that MCFAs have an "anti-Warburg effect". In a double-blind randomized trial (Personalized Prevention of Colorectal Cancer; NCT01105169), we found that 12-week personalized magnesium (Mg) supplementation led to significantly increased circulating levels of MCFAs, particularly caprylic acid (C8:0), which was due to enhanced microbial production. These novel findings suggest individuals with Mg sufficiency can receive supplies of MCFAs from microbiome whereas people with Mg deficiency cannot and so need MCFAs from intake. Thus, we hypothesized that the associations between intakes of C8:0 and risk of cancer mortality are modified by body Mg status. We tested this hypothesis in the NHANES, a nationally representative study. We recently developed the Mg depletion score (MDS) to assess Mg status and validated it against the invasive gold standard measure of Mg status. MDS performs better than either serum Mg or Mg intake at predicting Mg deficiency. We also found higher Mg intake was associated with reduced risks of inflammation and total mortality only among those with higher MDS scores, i.e., higher risk of losing Mg in the kidney. Thus, we examined if MDS modified the associations between intakes of MCFAs and risk of cancer mortality. Among 11,890 US adults aged ≥20 years over a median follow-up of 70 person-months, the associations between C8:0 intake and cancer mortality risk differed by MDS (Pinteraction=0.12). Higher C8:0 intake was associated with increased cancer mortality risk when MDS=0 (no risk of losing Mg; P-trend=0.03) after adjusting for all covariates, including dairy product intake. C8:0 intake was not related to risk of cancer mortality when MDS=1. Conversely, C8:0 intake may be associated with a reduced cancer mortality risk among those with MDS>1(high risk of losing Mg). In particular, higher C8:0 intake was significantly associated with a reduced risk of cancer mortality (P-trend<0.01) with an HR (95% CI) of 0.11 (0.02-0.84) for the highest quartile of C8:0 intake when Mg intake was above the Estimated Average Requirement. No associations were found for intakes of C6:0, C10:0 and C12:0. In summary, C8:0 can be generated by human gut microbiome through optimized Mg consumption; dietary intakes of C8:0 were associated with a reduced risk of cancer mortality among those at high risk of losing Mg, but with adequate Mg consumption; and intakes of C8:0 were related to an increased risk of cancer mortality among those with no risk of losing Mg. Citation Format: Lei Fan, Xiangzhu Zhu, Alexandra Shingina, Lihua Shu, Martha Shrubsole, Qi Dai. Synergism between medium-chain fatty acid intake and global magnesium status on the risk of cancer mortality in the National Health and Nutrition Examination Survey (NHANES) 2005-2014 [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl) nr 5894.

Magnesium intake and primary liver cancer incidence and mortality in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Abstract 4258: Magnesium Intake and Mortality Due to Liver Cancer and Other Liver Diseases: Results from the Third National Health and Nutrition Examination Survey Cohort

Associations Between Dietary Magnesium Intake and Hypertension, Diabetes, and Hyperlipidemia

Magnesium Intake and Mortality Due to Liver Diseases: Results from the Third National Health and Nutrition Examination Survey Cohort

Blood Magnesium Level and Risk of Hepatocellular Carcinoma in a Prospective Liver Cirrhosis Cohort

Abstract 6457: Blood magnesium level is associated with liver cancer risk in a prospective cohort of liver cirrhosis patients

Magnesium intake and incidence of pancreatic cancer: the VITamins and Lifestyle study

Abstract 5894: Synergism between medium-chain fatty acid intake and global magnesium status on the risk of cancer mortality in the National Health and Nutrition Examination Survey (NHANES) 2005-2014

Magnesium intake is inversely associated with risk of non-alcoholic fatty liver disease among American adults

Plasma Magnesium Concentrations And Risk Of Incident Cancer In Adults With Hypertension: A Nested Case-Control Study

Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study.

Effects of serum magnesium level on mortality in maintenance hemodialysis patients

The Association Between Dietary Magnesium Intake with Chronic Obstructive Pulmonary Disease and Lung Function in US Population: a Cross-sectional Study

Magnesium and the Risk of Cardiovascular Events: A Meta-Analysis of Prospective Cohort Studies

Appraising the Role of Circulating Concentrations of Micro-Nutrients in Epithelial Ovarian Cancer Risk: A Mendelian Randomization Analysis

Associations of minerals intake with colorectal cancer risk in the prostate, lung, colorectal, ovarian cancer screening trial

Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.

Integrative Omics Uncovers Low Tumorous Magnesium Content as A Driver Factor of Colorectal Cancer

Intakes of magnesium, calcium and risk of fatty liver disease and prediabetes.

Magnesium Intake and Incidence of Stroke: Meta-analysis of Cohort Studies